Actively Recruiting
Cancer Of the BReast Asanas Study (COBRA)
Led by UMC Utrecht · Updated on 2026-05-06
140
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
Sponsors
U
UMC Utrecht
Lead Sponsor
W
World Cancer Research Fund International
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rationale: Women with hormone-receptor positive breast cancer are usually prescribed endocrine therapy for a period of 5-10 years. This treatment reduces the risk of recurrence and improves overall survival in these women. Musculoskeletal complaints are a common (\~50%) negative consequence of endocrine treatment, which affects daily functioning and quality of life. These symptoms frequently result in early treatment discontinuation, which is associated with shorter disease-free survival. Musculoskeletal complaints are often pharmacologically treated with limited effect and accompanied by side-effects. Therefore, interventions to counteract musculoskeletal complaints are urgently needed in this population. A potential non-pharmacological option is yoga. In patients with osteoarthritis, there is emerging evidence that yoga is effective to reduce pain and stiffness and improve function. Yoga as treatment for musculoskeletal complaints that are associated with endocrine treatment is rarely investigated and mainly in small studies. Objective: The objective of the proposed study is to assess the effectiveness of a 4-month yoga program compared to a waiting list control group on musculoskeletal complaints in women with hormone-positive stage I-III breast cancer receiving endocrine treatment who report musculoskeletal complaints. Study design: The COBRA study is a randomized controlled trial with two study arms: a yoga- and a waiting list control group. Study population: For this study, 140 women with oestrogen-receptor positive stage I-III breast cancer on endocrine treatment (aromatase inhibitors or Tamoxifen; \>4 months) will be recruited. These women experience musculoskeletal complaints (\>3 months) which started or exacerbated after initiation of endocrine treatment. Furthermore, eligible women did not practice yoga in the last six months and are not planning to start yoga and are not highly physically active (i.e., \>150 minutes per week moderate-vigorous exercise). Intervention: The intervention consists of two one-hour sessions/week supervised yoga and once a week 30-minute yoga exercises at home. The 4-month yoga program will be an active form of yoga, such as Easy Vinyasa yoga, which is characterized by continuous slow movements linked with breathing. The waiting list control patients will be offered an online yoga program after the 4-month study period.
CONDITIONS
Official Title
Cancer Of the BReast Asanas Study (COBRA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with oestrogen-receptor positive stage I-III breast cancer
- Using aromatase inhibitors or Tamoxifen for more than 4 months and will continue for at least six months
- Completed primary treatments (chemotherapy, radiotherapy, surgery) at least 12 weeks ago
- Experiencing musculoskeletal complaints lasting over 3 months that started or worsened after starting endocrine therapy, with at least mild severity (pain score ≥ 3)
- Stable on menopausal symptom medication for at least three months and antidepressants for at least three weeks, if applicable
- Able to read, speak, and understand Dutch or English
You will not qualify if you...
- Physically active more than 150 minutes per week of moderate-to-vigorous or leisure and sports activities
- Practiced yoga regularly in the last 6 months or planning to start yoga soon
- Receiving or planning to receive structured psychological therapy during the study or unstable on psychotropic medication
- Participated in the intervention group of an exercise study during breast cancer treatment
- Unable to give informed consent or comply with study requirements
- Unable to attend training sessions for more than 3 weeks during the intervention
- Have a body mass index (BMI) over 35 kg/m2
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Utrecht (UMC Utrecht)
Utrecht, Netherlands, 85500 3508 GA
Actively Recruiting
Research Team
E
Evelyn Monninkhof, Dr.
CONTACT
S
Stefanie Veenhuizen, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here